Skip to content
What’s in the government’s omnibus spending package
The text of the 4,155-page, $1.7 trillion omnibus spending bill was delivered around ...
Read More
Teen opioid deaths are on the rise – but OTC Narcan could help
It’s no surprise the COVID-19 pandemic aggravated the United States’ already rampant opioid ...
Read More
Biden Administration seeks public input on how to support biotech
The federal government today released two calls for public input on how the ...
Read More
Mexico proposes amendments to biotech corn ban
On Friday, Mexican officials proposed amendments to the plan to ban imports of ...
Read More
BIO aids global harmonization, helping speed cures to patients
The process of holding clinical trials and gaining FDA approval takes up much ...
Read More
More parents oppose routine childhood vaccines since 2019, survey shows
One-third of parents now oppose public schools requiring students to get routine childhood ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
Federal Policy
Using AI In patent practice: Practical and ethical issues
The use of AI tools in the workplace is on the rise. This trend is equally true in the arena of patent practice. However, given ...
Federal Policy
BIO IP Conference looks at academics and perceptions of IP
The post-COVID era has been especially hard on patent lawyers working in the biopharma space. “I don’t think it’s an accident that during the COVID ...
Federal Policy
Patient advocates urge action on PPRV to help fight rare disease
Patient advocates retold emotional stories of lives saved, changed—or at risk—as they discussed one of the most important factors enabling breakthroughs in fighting rare diseases, ...
BIO Events
Who invented what? BIO IP panel tackles joint inventorship
We sometimes imagine the inventor of a patent as a lone vanguard leading the charge toward innovation, but in the era of team research and ...
Bioeconomy
Bayh-Dole at 45: Still an engine for innovation
A researcher working in a university lab makes a discovery that could lead to a new cure. Investors who see the potential of the discovery ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
International
Bio's View
House passes BIO-backed legislation to increase access to capital
Legislation to free up capital for small innovative firms by removing regulatory barriers for both companies and investors passed the ...
Read More
